Early Development Considerations for Innovative Combination Products: Guidance for Industry and FDA Staff

Information

Type

Guidance

Regulated products

Biologics, Drugs, Medical Devices

Topics

Combination Products

Published

September 1, 2006

Last updated

May 13, 2021

Description

This document provides guidance for the development of innovative combination products, aimed at industry and FDA staff.

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed